Tailoring therapy: Balancing toxicity and chronic allograft dysfunction

Transplantation Proceedings

Volumn 33, Issue 3 SUPPL. 1, 2001, Pages S7-S10

  Halloran, P F ^a   Melk, A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID;

ALLOGRAFT; BLOOD PRESSURE; DRUG INDUCED DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE INJURY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY DISEASE; KIDNEY FUNCTION; ORGAN DONOR; ORGAN TRANSPLANTATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; SURVIVAL; TOXICITY; TREATMENT OUTCOME;

AGE FACTORS; CALCINEURIN; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; TRANSPLANTS;

EID: 0034996307     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02054-1     Document Type: Article

References (9)

1. Hume DM, Merrill JP, Miller BF, et al: J Clin Invest 34:327, 1955
2. Jeannet M, Pinn VW, Flax MH, et al: N Engl J Med 282:111, 1970
3. Hariharan S, Johnson CP, Bresnahan BA, et al: N Engl J Med 342:605, 2000
4. Cicciarelli J, Iwaki Y, Mendenz R: In Cecka JM, Terasaki PI (eds): Clinical Transplants 1999. Los Angeles, Calif: UCLA Tissue Typing Laboratory; 2000, p. 335
5. Trpkov K, Campbell P, Pazderka F, et al: Transplantation 61:1586, 1996
6. Collins AB, Schneeberger EE, Pascual MA, et al: J Am Soc Nephrol 10:2208, 1999
7. Myers BD, Ross J, Newton L, et al: N Engl J Med 311:699, 1984
8. Sharon E, Kaplan D, Diamond HS: New Engl J Med 288:122, 1973
9. Hall BM, Tiller DJ, Hardie I, et al: N Engl J Med 318:1499, 1988